Likely delay to Bioethics Convention:
This article was originally published in Clinica
Agreement on the Council of Europe Bioethics Convention could be delayed until later this year. Although the text was cleared by the Council's parliamentary assembly on February 2nd, experts from the 33 member states demanded 20 further changes. These will now be considered by a committee of ministers acting on behalf of national governments. The assembly in early February avoided a controversy on embryo research by agreeing that this should be covered in detail by a separate protocol which is being drafted with less urgency.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.